ReviewBiomolecules2021

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor.

Raf Van Campenhout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.